Articles From: IIROC Trading Halt - PTQ to Alnylam Earns $7 Million Milestone Payment from Genzyme for Phase II Success with Patisiran (ALN-TTR02), an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)


2013/11/25
IIROC Trading Halt - PTQ Canada NewsWire TORONTO , Nov.
Sign-up for IIROC Trading Halt - PTQ investment picks
By Barbara Kollmeyer, MarketWatch LONDON (MarketWatch) -- European stock markets traded broadly higher on Monday, with investors in a mood to take on more risk after Iran made a nuclear deal with major world powers.
Sign-up for EUROPE MARKETS: Europe Stocks Move Higher On Iran-deal Relief investment picks
Company's Accredited Testing and Evaluation Laboratories Perform Security Assessments for Cloud Service Providers RESTON, Va.
Sign-up for Leidos Receives FedRAMP Accredited Third Party Assessment Organization Status investment picks
By Al Lewis Why stuff a turkey when you can stuff a shopping cart full of cheap, Chinese-made goods?
Sign-up for Al's Emporium: Happy Thanksgrabbing! investment picks
2013/11/25
Urban Oaks Builders LLC Selects Textura to Manage Construction Payment Management Process Canada NewsWire CHICAGO , Nov.
Sign-up for Urban Oaks Builders LLC Selects Textura to Manage Construction Payment Management Process investment picks
By Ben Fox Rubin National Oilwell Varco Inc. (NOV) named Robert Workman as the new chief executive of its soon-to-be spun-off distribution company, which will be called DistributionNOW.
Sign-up for National Oilwell Names Workman as Spinoff's CEO investment picks
2013/11/25
The Hunger Games: Catching Fire™ Blazes Trails In IMAX® With Estimated $18 Million Worldwide In Opening Weekend Canada NewsWire IMAX Has Its Best Three-Day November Opening In Debut Across 347 North American IMAX® Theatres, Earning $12.6 Million Domestically LOS ANGELES , Nov.
Sign-up for The Hunger Games: Catching Fire™ Blazes Trails In IMAX® With Estimated $18 Million Worldwide In Opening Weekend investment picks
2013/11/25
IMAX Has Its Best Three-Day November Opening In Debut Across 347 North American IMAX® Theatres, Earning $12.6 Million Domestically LOS ANGELES , Nov.
Sign-up for The Hunger Games: Catching Fire™ Blazes Trails In IMAX® With Estimated $18 Million Worldwide In Opening Weekend investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today reported financial results for its fiscal fourth quarter and year ended September 30, 2013.
Sign-up for Enanta Pharmaceuticals Reports Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2013 investment picks
2013/11/25
Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it recently filed an application for approval to begin a phase 2a clinical trial of its RNAi-based therapeutic candidate, ARC-520, for the potential treatment of chronic hepatitis B virus infection.
Sign-up for Arrowhead Submits Application to Begin Phase 2a Trial of ARC-520 for the Treatment of Chronic Hepatitis B Infection investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced positive top-line results from the Company’s pivotal Phase 3 clinical trial of its antibiotic candidate ceftolozane/tazobactam in complicated urinary tract infections (cUTI). Ceftolozane/tazobactam met its primary endpoint of statistical non-inferiority compared to levofloxacin (10% non-inferiority margin). The primary endpoint is a composite of microbiological eradication and clinical cure rate (composite cure rate) at 5 - 9 days after end of therapy (the Test of Cure visit). The 95% confidence interval around the treatment difference had lower and upper bounds of 2.3% and 14.6%, respectively, favoring ceftolozane/tazobactam. Results of the secondary analyses were consistent with and supportive of the primary outcome.
Sign-up for Cubist Announces Positive Top-Line Results from Phase 3 Trial of Investigational Antibiotic Ceftolozane/Tazobactam in Complicated Urinary Tract Infections investment picks
2013/11/25
ELKHART, Ind.
Sign-up for Drew Industries Declares Special Cash Dividend investment picks
2013/11/25
Corvex and Related to Engage in Active Dialogue with Fellow Shareholders to Identify Truly Independent Trustees NEW YORK , Nov.
Sign-up for Corvex And Related Deliver Formal Notice To CommonWealth REIT And Arbitration Panel As First Step In Consent Solicitation Process To Remove Entire Board investment picks
2013/11/25
AMARILLO, Texas , Nov.
Sign-up for Hastings Entertainment, Inc. Reports Results for the Third Quarter of Fiscal 2013 investment picks
2013/11/25
Avnel appoints Dr.
Sign-up for Avnel appoints Dr. Olivier Féménias as Vice President Geology investment picks
Rouse Properties, Inc. (the "Company" or "Rouse") (NYSE:RSE) a national owner of regional enclosed malls, today announced the closing of a new $510 million corporate credit facility, which replaced the Company’s existing $337.9 million credit facility which had been scheduled to mature in January, 2015.
Sign-up for Rouse Properties Closes New $510 Million Corporate Credit Facility investment picks
2013/11/25
Jones Group Inc. (JNY) is in advanced talks to be sold to Sycamore Partners LLC for about $1.3 billion, or $16 a share, Reuters reported Friday on its website, citing people familiar with the process.
Sign-up for Jones Group in Advanced Talks for Sale to Sycamore Partners -Reuters investment picks
2013/11/25
Company Implementing Plan to Ensure Safe and Reliable Service to Customers READING, Pa.
Sign-up for Penelec Union Locked Out After Rejecting Last, Best, Final Contract Offer investment picks
Ericsson to provide an innovative 3G smart meter communications solution in Victoria, Australia This solution communicates direct to a smart meter over an existing Australian public mobile network The standards-based approach adopted by Ericsson allows this solution to be replicated on 3G networks globally STOCKHOLM, Sweden, Nov.
Sign-up for SP AusNet chooses Ericsson's solution for smart meter communications investment picks
2013/11/25
DALLAS, Nov.
Sign-up for Blue Calypso to Present at the LD Micro Conference on December 3, 2013 investment picks
2013/11/25
Company will Resubmit the Contrave NDA in the Next Few Weeks - Potential Approval by June 2014 SAN DIEGO , Nov.
Sign-up for Orexigen Announces Successful Interim Analysis of Contrave Light Study investment picks
2013/11/25
Step-out drilling extends high-grade mineralization at Fortuna Silver's Trinidad North discovery Canada NewsWire Trading symbols: NYSE: FSM | TSX: FVI | BVL: FVI | Frankfurt : F4S.F Forward looking Statements This news release contains forward-looking statements which constitute "forward-looking information" within the meaning of applicable Canadian securities legislation and "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Sign-up for Step-out drilling extends high-grade mineralization at Fortuna Silver's Trinidad North discovery investment picks
2013/11/25
VANCOUVER , Nov.
Sign-up for Step-out drilling extends high-grade mineralization at Fortuna Silver's Trinidad North discovery investment picks
2013/11/25
-- Agency Subscribes to Rentrak's TV Ratings Currency to Drive Increased Efficiency and Effectiveness for Political Buys --
Sign-up for Target Enterprises Signs Local Market TV Ratings Agreement With Rentrak For Upcoming Political Season investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: IIROC Trading Halt - PTQ to Alnylam Earns $7 Million Milestone Payment from Genzyme for Phase II Success with Patisiran (ALN-TTR02), an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity